Retatrutide

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

1. 1

   1–2 Weeks

   Appetite reduction is typically the first noticeable change, often described as more pronounced than single-pathway GLP-1 drugs.

2. 2

   3–4 Weeks

   Fullness after smaller meals tends to become more consistent as the dose is titrated.

3. 3

   5–7 Weeks

   Early weight changes are commonly reported as more rapid than with GLP-1-only compounds.

4. 4

   8–10 Weeks

   Energy levels and clothing fit are commonly the next noticeable changes.

5. 5

   11–15 Weeks

   Continued, steady weight and appetite changes are typical through this period.

6. 6

   16–20 Weeks

   This stage is commonly described as when body composition changes become clearly visible.

7. 7

   21–24 Weeks

   Many users are approaching a maintenance phase, with substantial cumulative change reported by trial participants over a similar timeframe.

⚠️ Research context only. This is not medical advice and results are not guaranteed.